Statin repurposing in gastrointestinal cancer: from metabolic reprogramming to immunoregulationMiaorong Xu on 30 de December de 2025 at 11:00
J Leukoc Biol. 2025 Dec 30:qiaf187. doi: 10.1093/jleuko/qiaf187. Online ahead of print. ABSTRACT Cholesterol metabolism plays a pivotal role in gastrointestinal (GI) cancers, from fuelling tumor growth, facilitating metastatic niche formation, shaping tumor immunosuppressive microenvironment to promoting immunotherapy resistance. Paradoxically, cholesterol may also exert context-dependent protective effects. Statins, the most widely prescribed cholesterol-lowering drugs, function … Read more